Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Let’s stop being skeptical about statins

Dr. Saurabh Jha
Meds
December 6, 2016
Share
Tweet
Share

If you’re going to indulge in anticipatory medicine, it is best to anticipate those at highest risk. An elegant study by Wald et al in the NEJM shows how precision primary prevention can be done. The researchers screened toddlers, who presented routinely to their general practitioners for vaccinations, for an uncommon, but not rare, familial predisposition to high cholesterol known as heterozygous familial hypercholesterolemia (FH), in which premature cardiovascular death can be deferred by statins and lifestyle changes. Blood drawn from the toddlers by a heel prick was tested for serum cholesterol and genetic mutations indicative of heterozygous familial hypercholesterolemia (FH). The parents of toddlers who met criteria for FH were also tested for cholesterol and genetic mutations. Obviously, identifying affected parents and increasing their longevity is also beneficial for their children.

Researchers defined familial hypercholesterolemia in two ways:

  1. Elevated cholesterol and a gene mutation – phenotype positive, genotype positive group.
  2. Elevated cholesterol on two occasions but no mutation – phenotype positive, genotype unknown group. It was assumed that children in this group have genetic mutations which we’re presently unaware of.

The mutations — there are 48 — present in 37 out of 10,095 children, were picked up in 20/37 children when high cholesterol was defined at the 99.2nd percentile, and in 32/37 children when high cholesterol was defined at the 95th percentile. The more stringent threshold for high cholesterol missed 46% (nearly half), and the less stringent missed 14%, of carriers of known mutations for FH. The frequency of the “phenotype positive, genotype unknown” — i.e. those who had elevated cholesterol on two occasions, but did not have the known mutations for FH, was 8 out 10, 095 children (0.08%) — I suspect this number may be higher when screening is rolled out en masse.

What threshold for “high cholesterol” should be used? If we’re going to screen for familial hypercholesterolemia, there’s no point missing half the children who carry the mutations. It makes sense using the lower threshold of the 95th percentile of population serum cholesterol to define hypercholesterolemia.

At first, it seems we’re throwing a wide net to catch rare trout. However, the net is no wider than other screening nets. Applying the more liberal threshold for elevated cholesterol, 40 cases of FH were found in 10,095 kids, which is a number-needed-to screen (NNS) of 250. When you include the parents who, unbeknownst, had FH or high cholesterol, that’s an NNS of 125 — hardly an unrespectable NNS compared with cancer screening — for smokers at high risk for lung cancer, the NNS is 320 with screening with low-dose CT.

There are still uncertainties because of the “inverse problem” which haunts genomics. Just because people who die prematurely from CV disease have certain genetic mutations which elevate cholesterol, doesn’t mean that everyone with that genetic mutation will die prematurely. This genotype-phenotype-outcome mismatch is nicely explained by Siddhartha Mukherjee in The Gene.

The authors make clear that mutation alone doesn’t make risk, and cholesterol must also be elevated to define familial hypercholesterolemia. Because we must assume that anyone with a mutation and high cholesterol may die prematurely — we must assume something — and that they’d benefit from lifestyle changes and statins, inevitably, some will be overtreated. The natural histories of the “phenotype positive, genotype positive” and “phenotype positive, genotype unknown” — by natural history, I mean how many in these cohorts die prematurely and at what age — is a knowledge gap that’ll likely and unsurprisingly be permanent. Would you volunteer your child, who just had FH detected, to remain untreated to study this intriguing question for mankind? I wouldn’t.

The study asks a probing philosophical question. Is familial hypercholesterolemia a disease or a risk factor, or is the distinction between risk factor and disease a distinction without a difference? It will be tempting to start adolescents with FH on statins, whilst encouraging them to swing on monkey bars. It is hard to see how statins can be avoided in adolescents known to have FH, and for their management to be largely lifestyle based. Prescribing exercise to children at high risk of premature death from cardiovascular disease sounds good in theory, but if participating in sports requires a doctor’s prescription, how successful can that prescription be? I mean getting off the couch surely doesn’t need shared decision making. And whether the children get off the couch, sooner or later, their parents might ask for pharmacological means to reduce their risk of premature death, which I believe would be wholly justified.

I’ve been told by some cardiologists that in those genetically predisposed to high cholesterol, running or swinging on monkey bars, though helpful, won’t alone reduce their risk of dying early, at least not without a little help from statins. I always take cardiologists at their word. What choice do I have? My life could depend on them.

Nevertheless, statin skeptics should occasionally suspend their skepticism. The group uncovered by Wald and colleagues is an apt group for suspending skepticism about statins and primary prevention.

Saurabh Jha is a radiologist and can be reached on Twitter @RogueRad.  This article originally appeared in the Health Care Blog.

Image credit: Shutterstock.com

Prev

The days of the drug rep have come to an end

December 6, 2016 Kevin 4
…
Next

I never want to be a government-employed physician. Here's why.

December 6, 2016 Kevin 5
…

ADVERTISEMENT

Tagged as: Cardiology

Post navigation

< Previous Post
The days of the drug rep have come to an end
Next Post >
I never want to be a government-employed physician. Here's why.

ADVERTISEMENT

More by Dr. Saurabh Jha

  • Masks are an effigy of American technocratic incompetence

    Dr. Saurabh Jha
  • False negative: COVID-19 testing’s catch-22

    Dr. Saurabh Jha
  • Why the Lancet’s editorial on Kashmir is unhelpful

    Dr. Saurabh Jha

Related Posts

  • When should you prescribe statins for older adults?

    Kenneth Lin, MD
  • Let’s talk residency: COVID edition

    Angela Awad and Catherine Tawfik
  • It’s time to stop being skeptical of hospital chaplains

    Ilaria Simeone
  • We have a shot at preventing cervical cancer

    Lisa N. Abaid, MD, MPH
  • Upset with the government’s pandemic response? Let’s elect more scientists and doctors.

    Shahdabul Faraz, MD
  • The public health emergency brought health care into the 21st century. Let’s keep moving forward.

    Stephen Parodi, MD

More in Meds

  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • Most Popular

  • Past Week

    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • High blood pressure’s hidden impact on kidney health in older adults

      Edmond Kubi Appiah, MPH | Conditions
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • The physician who turned burnout into a mission for change

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Meeting transgender patients where they are: a health care imperative

      Tyler B. Evans, MD, MPH | Physician
    • How to break the cycle of judgment in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How value-based care transforms chronic kidney disease management

      Timothy Pflederer, MD | Conditions
    • Why rigorous training is vital for today’s surgeons

      Philip Alford, MD | Physician
    • The hidden cost of professionalism in medical training

      Hannah Wulk | Education
    • The cost of ending shadowing in medical education

      Matthew Ryan, MD, PhD | Education

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • High blood pressure’s hidden impact on kidney health in older adults

      Edmond Kubi Appiah, MPH | Conditions
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • The physician who turned burnout into a mission for change

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Meeting transgender patients where they are: a health care imperative

      Tyler B. Evans, MD, MPH | Physician
    • How to break the cycle of judgment in medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How value-based care transforms chronic kidney disease management

      Timothy Pflederer, MD | Conditions
    • Why rigorous training is vital for today’s surgeons

      Philip Alford, MD | Physician
    • The hidden cost of professionalism in medical training

      Hannah Wulk | Education
    • The cost of ending shadowing in medical education

      Matthew Ryan, MD, PhD | Education

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Let’s stop being skeptical about statins
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...